Fatal pulmonary artery thrombosis in a patient with Behçet's disease, activated protein C resistance and hyperhomocystinemia.
暂无分享,去创建一个
[1] O. Ozcebe,et al. Behçet's disease. , 2019, The New England journal of medicine.
[2] A. Oner,et al. Factor V Leiden mutation in patients with Behçet's disease. , 1998, The Journal of rheumatology.
[3] Ş. Kirazlı,et al. Activated protein C resistance in Behçet's disease , 1998, Rheumatology International.
[4] A. Al-Dalaan,et al. Association of factor V Leiden with Behçet's disease. , 1997, The Journal of rheumatology.
[5] G. Ehrlich. Vasculitis in Behçet's disease. , 1997, International reviews of immunology.
[6] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[7] M. Inanç,et al. Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. , 1996, British journal of rheumatology.
[8] O. Ozcebe,et al. Haemostatic markers of procoagulant imbalance in Behçet's disease , 1996, European journal of haematology.
[9] P. Mannucci,et al. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. , 1996, Blood.
[10] J. Piette,et al. Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease. , 1995, Annals of the rheumatic diseases.
[11] F. Numan,et al. Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. , 1994, British journal of rheumatology.
[12] D. Menon,et al. Coagulation and Fibrinolytic Activity in Behçet's Disease , 1991, Thrombosis and Haemostasis.